A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients with Huntington's Disease.

  • Bertram, Kelly (Primary Chief Investigator (PCI))
  • Burn, Katherine, (Project Manager)

Project: Research

StatusActive
Effective start/end date18/09/19 → 31/10/20
View all
View less

Keywords

  • Neuroscience
  • Huntington's Disease
  • Clinical trial